TY - JOUR
T1 - Intrahepatic fat, abdominal adipose tissues, and metabolic state
T2 - magnetic resonance imaging study
AU - Yaskolka Meir, Anat
AU - Tene, Lilac
AU - Cohen, Noa
AU - Shelef, Ilan
AU - Schwarzfuchs, Dan
AU - Gepner, Yftach
AU - Zelicha, Hila
AU - Rein, Michal
AU - Bril, Nitzan
AU - Serfaty, Dana
AU - Kenigsbuch, Shira
AU - Chassidim, Yoash
AU - Sarusy, Benjamin
AU - Dicker, Dror
AU - Thiery, Joachim
AU - Ceglarek, Uta
AU - Stumvoll, Michael
AU - Blüher, Matthias
AU - Stampfer, Meir J.
AU - Rudich, Assaf
AU - Shai, Iris
N1 - Funding Information: We thank the CENTRAL participants for their significant contribution. We thank Osnat Tangi-Rosental, Eyal Goshen, Dr Rafi Gonen, Dr Lena Novak, Victor Haddad, Roman Tsirkin, David Shushan, Shula Witkow, Liz Shabtay, Julia Kovshan, Hadar Cohen, and Dr Moti Salti for their valuable contributions for this study. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. This work was supported by grants from the Israel Science Foundation, the Deutsche, Forschungsgemeinschaft (DFG) (SFB1052) “obesity mechanisms” (project B8), Israeli Ministry of Science and Technology (grant No. 3-13604), and the Dr Robert C. and Veronica Atkins Research Foundation. The foundation was not involved in any stage of the design, conduct, or analysis of the study and had no access to the study results before publication. Anat Yaskolka Meir is a recipient of the Kreitman Doctoral Fellowship at the Ben-Gurion University of the Negev. Publisher Copyright: Copyright © 2017 John Wiley & Sons, Ltd.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Background: Intrahepatic fat (IHF) is best known to associate with waist circumference (WC) and visceral adipose tissue (VAT), but its relation to abdominal subcutaneous adipose tissue is controversial. While IHF ≥ 5% dichotomously defines fatty liver, %IHF is rarely considered as a continuous variable that includes the normal range. In this study, we aimed to evaluate %IHF association with abdominal fat subdepots, pancreatic, and renal-sinus fats. Methods: We evaluated %IHF, abdominal fat subdepots, %pancreatic, and renal-sinus fats, among individuals with moderate abdominal obesity, using 3-Tesla magnetic resonance imaging. Results: Among 275 participants, %IHF widely ranged (0.01%-50.4%) and was lower in women (1.6%) than men (7.3%; P <.001). In an age, sex, and WC-adjusted models, VAT area (P <.006) was directly associated with %IHF, while superficial–subcutaneous adipose tissue proportion was inversely associated with %IHF (P <.006). In these models, renal-sinus fat was positively associated with %IHF (P =.005). In an age, sex, WC, and VAT-adjusted models, elevated liver enzymes, glycemic, lipid, and inflammatory biomarkers were associated with increased %IHF (P <.003 for all). In these models, the associations remained robust even within the normal range strata of IHF < 5% for triglycerides and chemerin (P ≤.004 for all). For the diagnosis of fatty liver, the joint area under the curve of WC, alanine-aminotransferase, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance was 0.84(95% CI, 0.79-0.89). Conclusions: Intrahepatic fat is differentially associated with abdominal fat subdepots. Intrahepatic-fat as a continuous variable could be predicted by specific traditional parameters, even within the current normal range, and partially independent of VAT.
AB - Background: Intrahepatic fat (IHF) is best known to associate with waist circumference (WC) and visceral adipose tissue (VAT), but its relation to abdominal subcutaneous adipose tissue is controversial. While IHF ≥ 5% dichotomously defines fatty liver, %IHF is rarely considered as a continuous variable that includes the normal range. In this study, we aimed to evaluate %IHF association with abdominal fat subdepots, pancreatic, and renal-sinus fats. Methods: We evaluated %IHF, abdominal fat subdepots, %pancreatic, and renal-sinus fats, among individuals with moderate abdominal obesity, using 3-Tesla magnetic resonance imaging. Results: Among 275 participants, %IHF widely ranged (0.01%-50.4%) and was lower in women (1.6%) than men (7.3%; P <.001). In an age, sex, and WC-adjusted models, VAT area (P <.006) was directly associated with %IHF, while superficial–subcutaneous adipose tissue proportion was inversely associated with %IHF (P <.006). In these models, renal-sinus fat was positively associated with %IHF (P =.005). In an age, sex, WC, and VAT-adjusted models, elevated liver enzymes, glycemic, lipid, and inflammatory biomarkers were associated with increased %IHF (P <.003 for all). In these models, the associations remained robust even within the normal range strata of IHF < 5% for triglycerides and chemerin (P ≤.004 for all). For the diagnosis of fatty liver, the joint area under the curve of WC, alanine-aminotransferase, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance was 0.84(95% CI, 0.79-0.89). Conclusions: Intrahepatic fat is differentially associated with abdominal fat subdepots. Intrahepatic-fat as a continuous variable could be predicted by specific traditional parameters, even within the current normal range, and partially independent of VAT.
KW - MRI
KW - deep subcutaneous adipose tissue
KW - intrahepatic fat
KW - superficial subcutaneous adipose tissue
KW - visceral adipose tissue
UR - http://www.scopus.com/inward/record.url?scp=85015317810&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/dmrr.2888
DO - https://doi.org/10.1002/dmrr.2888
M3 - Article
SN - 1520-7552
VL - 33
JO - Diabetes/Metabolism Research and Reviews
JF - Diabetes/Metabolism Research and Reviews
IS - 5
M1 - e2888
ER -